摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 3-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)propionate | 108299-30-5

中文名称
——
中文别名
——
英文名称
ethyl 3-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)propionate
英文别名
ethyl 3-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)propanoate;3-(1-oxo-1,2,3,4-tetrahydro-[2]naphthyl)-propionic acid ethyl ester;3-(1-Oxo-1,2,3,4-tetrahydro-[2]naphthyl)-propionsaeure-aethylester;2-(2-Ethoxycarbonylethyl)-3,4-dihydro-1(2H)-naphthalenone;ethyl 1,2,3,4-tetrahydro-1-oxo-2-naphthalene-propanoate;ethyl 3-(1-oxo-3,4-dihydro-2H-naphthalen-2-yl)propanoate
ethyl 3-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)propionate化学式
CAS
108299-30-5
化学式
C15H18O3
mdl
——
分子量
246.306
InChiKey
GRXHCNGPFAOIPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    182-183 °C(Press: 6 Torr)
  • 密度:
    1.1206 g/cm3

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    ethyl 3-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)propionate氢氧化钾 作用下, 以 为溶剂, 反应 5.0h, 以96%的产率得到3-(1-oxo-1,2,3,4-tetrahydronaphthalen-2-yl)propanoic acid
    参考文献:
    名称:
    Construction of Fused Cyclooctanoid Ring Systems via Seven-Membered Ring Carbonyl Ylides
    摘要:
    一系列连接到环戊酮/环己酮/1-四氢萘酮单元的α-重氮羰基化合物通过使用重氮甲烷溶液,通过铑产生的羰基叶立德构建了各种融合的环辛烷环体系。铑(II)醋酸二聚体与各种α-重氮羰基化合物的反应生成了瞬态的七元环羰基叶立德,这些叶立德与亲二极体如N-苯基马来酰亚胺、对苯醌和DMAD进行了方便的1,3-偶极环加成反应,以串联方式提供了多种融合的环氧桥接环辛烷环体系。有趣的是,通过七元环羰基叶立德的分子内质子转移生成了一个oxepine环体系。当对苯醌作为亲二极体时,得到了一个三氧杂多环化合物。报道了对融合环辛烷类衍生物的单晶X射线分析,以明确确定融合环氧桥接环辛烷环体系的结构和立体化学;进一步分析揭示了固态结构中存在的独特分子间C-H···π相互作用模式。
    DOI:
    10.1246/bcsj.75.801
  • 作为产物:
    参考文献:
    名称:
    还原吲哚制备六氢咔唑衍生物
    摘要:
    在亚胺离子中间体的阶段,通过用氢化硼酸盐试剂还原而中断了苯基肼衍生物的费歇尔吲哚化,在位置4a提供了具有官能化侧链的六氢咔唑衍生物。用于该转化的环状δ-氧代酯是从丙烯酸乙酯和环烷酮获得的。
    DOI:
    10.1002/ejoc.202001226
点击查看最新优质反应信息

文献信息

  • Construction of Fused Cyclooctanoid Ring Systems via Seven-Membered Ring Carbonyl Ylides
    作者:Sengodagounder Muthusamy、Srinivasarao Arulananda Babu、Chidambaram Gunanathan、Eringathodi Suresh、Parthasarathi Dastidar
    DOI:10.1246/bcsj.75.801
    日期:2002.4
    A series of α-diazo carbonyl compounds tethered to cyclopentanone/cyclohexanone/1-tetralone units have been synthesized using a diazomethane solution to construct various fused cyclooctane ring systems via rhodium-generated carbonyl ylides. The reaction of rhodium(II) acetate dimer with various α-diazo carbonyl compounds generated transient cyclic seven-membered ring carbonyl ylides, which underwent facile 1,3-dipolar cycloadditions with dipolarophiles, like N-phenylmaleimide, p-benzoquinone, and DMAD to furnish a variety of fused epoxy-bridged cyclooctane ring systems in a tandem manner. Interestingly, an oxepine ring system was generated via an intramolecular proton transfer of a seven-membered ring carbonyl ylide. A tri-oxa polycyclic compound was obtained in the case of p-benzoquinone as dipolarophile. A single-crystal X-ray analysis of a fused cyclootanoid derivative is reported to decisively establish the structure and stereochemistry of the fused epoxy-bridged cyclooctane ring systems; a further analysis revealed the existence of a unique intermolecular C–H···π interaction motif in the solid-state architecture.
    一系列连接到环戊酮/环己酮/1-四氢萘酮单元的α-重氮羰基化合物通过使用重氮甲烷溶液,通过铑产生的羰基叶立德构建了各种融合的环辛烷环体系。铑(II)醋酸二聚体与各种α-重氮羰基化合物的反应生成了瞬态的七元环羰基叶立德,这些叶立德与亲二极体如N-苯基马来酰亚胺、对苯醌和DMAD进行了方便的1,3-偶极环加成反应,以串联方式提供了多种融合的环氧桥接环辛烷环体系。有趣的是,通过七元环羰基叶立德的分子内质子转移生成了一个oxepine环体系。当对苯醌作为亲二极体时,得到了一个三氧杂多环化合物。报道了对融合环辛烷类衍生物的单晶X射线分析,以明确确定融合环氧桥接环辛烷环体系的结构和立体化学;进一步分析揭示了固态结构中存在的独特分子间C-H···π相互作用模式。
  • Biogenic amine uptake inhibitors
    申请人:Abbott Laboratories
    公开号:US05180733A1
    公开(公告)日:1993-01-19
    Compounds of the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein M is 0, 1 or 2 and n is 0 or 1; R.sup.1 is hydrogen or lower alkyl; R.sup.2 is C.sub.1 -C.sub.6 -alkyl substituted with a heterocyclic group or C.sub.7 -C.sub.16 -arylalkyl, wherein the aryl group is unsubstituted or substituted with from one to three non-hydrogen members independently selected from the group consisting of halogen, C.sub.1 -C.sub.6 -alkyl, halo-C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, hydroxy, amino and C.sub.1 -C.sub.6 -alkylamino; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are independently selected from the group consisting of hydrogen, C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.6 -alkyl, halogen, and halo-C.sub.1 -C.sub.6 -alkyl, or any two of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 taken together form a methylenedioxy group; and R.sup.7 is hydrogen or C.sub.1 -C.sub.6 -alkyl. These compounds are useful as inhibitors of the neuronal uptake of biogenic amines and for the treatment of affective disorders, such as, for example, depression.
    该公式化合物为:##STR1##或其药学上可接受的盐,其中M为0、1或2,n为0或1;R.sup.1为氢或较低的烷基;R.sup.2为C.sub.1 -C.sub.6 -烷基,其上取代有杂环基团或C.sub.7 -C.sub.16 -芳基烷基,其中芳基未取代或取代有1至3个非氢成员,独立选择自卤素、C.sub.1 -C.sub.6 -烷基、卤代C.sub.1 -C.sub.6 -烷基、C.sub.1 -C.sub.6 -烷氧基、羟基、氨基和C.sub.1 -C.sub.6 -烷基氨基;R.sup.3、R.sup.4、R.sup.5和R.sup.6分别选自氢、C.sub.1 -C.sub.6 -烷氧基、C.sub.1 -C.sub.6 -烷基、卤素和卤代C.sub.1 -C.sub.6 -烷基的群,或R.sup.3、R.sup.4、R.sup.5和R.sup.6中的任意两个一起形成亚甲二氧基基团;R.sup.7为氢或C.sub.1 -C.sub.6 -烷基。这些化合物可用作生物胺神经元摄取抑制剂,用于治疗情感障碍,例如抑郁症。
  • Biogentic amine uptake inhibitors
    申请人:Abbott Laboratories
    公开号:US05248677A1
    公开(公告)日:1993-09-28
    Compounds of the formula: ##STR1## or a pharmaceutically acceptable salt thereof, wherein m is 0, 1 or 2 and n is 0 or 1; R.sup.1 is hydrogen or lower alkyl; R.sup.2 is C.sub.1 -C.sub.6 -alkyl substituted with a heterocyclic group or C.sub.7 -C.sub.16 -arylalkyl, wherein the aryl group is unsubstituted or substituted with from one to three non-hydrogen members independently selected from the group consisting of halogen, C.sub.1 -C.sub.6 -alkyl, halo-C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, hydroxy, amino and C.sub.1 -C.sub.6 -alkylamino; R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are independently selected from the group consisting of hydrogen, C.sub.1 -C.sub.6 -alkoxy, C.sub.1 -C.sub.6 -alkyl, halogen, and halo-C.sub.1 -C.sub.6 -alkyl, or any two of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 taken together form a methylenedioxy group; and R.sup.7 is hydrogen or C.sub.1 -C.sub.6 -alkyl. These compounds are useful as inhibitors of the neuronal uptake of biogenic amines and for the treatment of affective disorders, such as, for example, depression.
    该式化合物为:##STR1## 或其药用可接受的盐,其中m为0、1或2,n为0或1;R.sup.1为氢或较低的烷基;R.sup.2为C.sub.1-C.sub.6-烷基,其上取代有杂环基团或C.sub.7-C.sub.16-芳基烷基,其中芳基未取代或取代有1至3个非氢成员,独立选自卤素、C.sub.1-C.sub.6-烷基、卤代C.sub.1-C.sub.6-烷基、C.sub.1-C.sub.6-氧烷基、羟基、氨基和C.sub.1-C.sub.6-烷基氨基;R.sup.3、R.sup.4、R.sup.5和R.sup.6独立选自氢、C.sub.1-C.sub.6-氧烷基、C.sub.1-C.sub.6-烷基、卤素和卤代C.sub.1-C.sub.6-烷基,或R.sup.3、R.sup.4、R.sup.5和R.sup.6中的任意两个组成亚甲二氧基基团;R.sup.7为氢或C.sub.1-C.sub.6-烷基。这些化合物可用作生物胺神经元摄取抑制剂,用于治疗情感障碍,例如抑郁症。
  • 1-\x9b.omega.-(3,4-dihydro-2-naphthalenyl)alkyl!-cyclic amine derivatives,
    申请人:Dainippon Pharmaceutical Co., Ltd.
    公开号:US05847159A1
    公开(公告)日:1998-12-08
    1-\x9b.omega.-(3,4-Dihydro-2-naphthalenyl)alkyl!cyclic amine derivative of the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 are H, halogen, OH, alkyl, alkoxy, hydroxymethyl, etc., or R.sup.1 and R.sup.2 combine to form methylenedioxy, trimethylene, etc., R.sup.3 is H, etc., R.sup.4 is H, OH, alkyl, etc., R.sup.5 is H, alkyl, etc., p is integer of from 2 to 6, and q is integer of from 3 to 7, provided that when p is 2, and q is 5, R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are not simultaneously H, or salts thereof, or N-oxide derivatives thereof, or a process for preparing the same, or pharmaceutical composition containing the same. The compounds of the present invention show potent inhibitory effect on the micturition reflex, and are useful as agents for treatment of frequent urination and urinary incontinence.
    化合物的式(I)为:1-\x9b.omega.-(3,4-二氢-2-萘基)烷基!环状胺衍生物,其中R.sup.1和R.sup.2为H、卤素、OH、烷基、烷氧基、羟甲基等,或R.sup.1和R.sup.2结合形成亚甲二氧基、三亚甲基等,R.sup.3为H等,R.sup.4为H、OH、烷基等,R.sup.5为H、烷基等,p为2到6的整数,q为3到7的整数,但当p为2,q为5时,R.sup.1、R.sup.2、R.sup.3、R.sup.4和R.sup.5不能同时为H,或其盐,或其N-氧化物衍生物,或制备它们的方法,或包含它们的制药组合物。本发明化合物表现出强效的抑制排尿反射的作用,可用作治疗频繁排尿和尿失禁的药物。
  • DBU Promoted Deformylative/Dehalogenative Difunctionalization to Access β‐Bromovinyl Aldehydes Derived from Tetralones**
    作者:Madan Sau、Sapana Dubey、Shreya Roy、Shubhankar Samanta、Tapas Das
    DOI:10.1002/ejoc.202300788
    日期:——
    Metal-free deformylative/dehalogenative carbonylation, Michael addition of β-bromovinyl aldehydes for the synthesis of δ-oxo esters and vinyl ethers have been reported. Nucleophilic and organo-catalytic behaviour of DBU is explored and the regeneration of the parent starting material from the vinyl ether is also highlighted.
    已经报道了无金属脱酰基/脱卤羰基化、β-溴乙烯基醛的迈克尔加成用于合成 δ-氧代酯和乙烯基醚。探索了 DBU 的亲核和有机催化行为,并重点介绍了乙烯基醚母体原料的再生。
查看更多

同类化合物

(S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 顺式-4-(4-氯苯基)-1,2,3,4-四氢-N-甲基-1-萘胺盐酸盐 顺式-4-(3,4-二氯苯基)-1,2,3,4-四氢N-叔丁氧羰基-1-萘胺 顺式-1-苯甲酰氧基-2-二甲基氨基-1,2,3,4-四氢萘 顺式-1,2,3,4-四氢-5-环氧丙氧基-2,3-萘二醇 顺式-(1S,4S)-N-甲基-4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺扁桃酸盐 顺-5,6,7,8-四氢-6,7-二羟基-1-萘酚 顺-(+)-5-甲氧基-1-甲基-2-(二正丙基氨基)萘满马来酸 阿洛米酮 阿戈美拉汀杂质醇(A) 阿戈美拉汀杂质 钠2-羟基-7-甲氧基-1,2,3,4-四氢-2-萘磺酸酯 金钟醇 邻烯丙基苯基溴化镁 那高利特盐酸盐 那高利特 过氧化,1,1-二甲基乙基1,2,3,4-四氢-1-萘基 贝多拉君 螺<4.7>十二烷 蔡醇酮 萘磺酸,二癸基-1,2,3,4-四氢- 萘并[2,3-d]咪唑,2-乙基-5,6,7,8-四氢-(6CI) 萘亚胺 苯甲酸-(5,6,7,8-四氢-[2]萘基酯) 苯甲丁氮酮 苯甲丁氮酮 苯甲丁氮酮 苯并烯氟菌唑 舍曲林二甲基杂质盐酸盐 舍曲林EP杂质B 舍曲林 羟甲基四氢萘酚 美曲唑啉 罗替戈汀硫酸盐 罗替戈汀杂质18 罗替戈汀中间体 罗替戈汀中间体 罗替戈汀 罗替戈汀 纳多洛尔杂质 米贝地尔(二盐酸盐) 盐酸舍曲林 盐酸舍曲林 盐酸罗替戈汀 盐酸左布诺洛尔 盐酸四氢唑林 甲基缩合物 甲基6-[1-(3,5,5,8,8-五甲基-5,6,7,8-四氢-2-萘基)环丙基]烟酸酯 甲基-(2-吡咯烷-1-基甲基-1,2,3,4-四氢-萘-2-基)-胺 环丙烯并[a]茚,1-溴-1-氟-1,1a,6,6a-四氢-